show less
show more
@hotloss7
COVID-19 characterized by refractory hypoxemia increases patient mortality because of immunosuppression effects. This study aimed to evaluate the efficacy of immunomodulatory with thymosin α1 for critical COVID-19 patients.
This multicenter retrospective cohort study was performed in 8 government-designated treatment centers for […] View
-
Jennings Green posted an update a month ago
COVID-19 characterized by refractory hypoxemia increases patient mortality because of immunosuppression effects. This study aimed to evaluate the efficacy of immunomodulatory with thymosin α1 for critical COVID-19 patients.
This multicenter retrospective cohort study was performed in 8 government-designated treatment centers for COVID-19…[Read more]
-
Jennings Green became a registered member a month ago
